Clinical Scorecard: A Liver Nodule Exhibiting Arterial Enhancement and Washout in a Patient with Alcohol-Related and Metabolic Liver Disease

At a Glance

Key Highlights

• Patient presented with a 5.3-cm hepatic nodule and advanced hepatic fibrosis.
• MRI findings fulfilled LI-RADS 5 criteria, suggesting hypervascular tumor.
• Histopathological analysis confirmed diagnosis of primary hepatic GIST.
• Standard treatment involved surgical resection followed by adjuvant imatinib therapy.
• Primary hepatic GISTs are rare, with only approximately 40 cases reported.

Guideline-Based Recommendations

Diagnosis

• Differential diagnosis should include hypervascular tumors and GIST based on imaging findings.

Management

• Surgical resection is the standard treatment for localized GIST.

Monitoring & Follow-up

• Adjuvant imatinib therapy is recommended for high-risk cases.

Risks

• Consideration of rare hepatic tumors in patients with chronic liver disease and typical HCC imaging features.

Patient & Prescribing Data

Patients with hepatic GIST and chronic liver disease.

Imatinib therapy (400 mg once daily) is indicated for high-risk cases post-surgery.

Clinical Best Practices

• Utilize dynamic contrast-enhanced MRI for characterization of hepatic lesions.
• Consider advanced liver disease when interpreting imaging findings.

Related Resources & Content

• Barcelona Clinic Liver Cancer Guidelines
• Gastrointestinal Stromal Tumors Overview